These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

986 related items for PubMed ID: 17497342

  • 1. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R, Banach M, Piechota M, Kowalski J, Barylski M, Cierniewski C, Pawlicki L.
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H.
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [Abstract] [Full Text] [Related]

  • 5. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
    Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J, Linnaluoto M, Peuhkurinen K, Anglo-Scandinavian Cardiac Outcomes Trial Investigators.
    Int J Cardiol; 2004 Nov; 97(2):251-6. PubMed ID: 15458692
    [Abstract] [Full Text] [Related]

  • 6. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension.
    Yasumoto K, Takata M, Ueno H, Tomita S, Tomoda F, Inoue H.
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):921-4. PubMed ID: 10509551
    [Abstract] [Full Text] [Related]

  • 7. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC.
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS, CREED Investigstors. The Cardiovascular Risk Extended Evaluation.
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension].
    Kosmala W, Spring A.
    Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098
    [Abstract] [Full Text] [Related]

  • 13. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, Guasti L, Venco A.
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide.
    Sugihara K, Fujimoto S, Motomiya Y, Hashimoto T, Nakamura S, Dohi K.
    Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091
    [Abstract] [Full Text] [Related]

  • 17. Correlation of serum BNP and ET-1 levels with cardiac pump function and ventricular remodeling in patients with heart failure.
    Qin L, Liu X, Li Y.
    Cell Mol Biol (Noisy-le-grand); 2020 Jun 05; 66(3):125-131. PubMed ID: 32538758
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T.
    Am J Med; 1995 Mar 05; 98(3):257-65. PubMed ID: 7872342
    [Abstract] [Full Text] [Related]

  • 20. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C, Metzele A, Kochs M, Hombach V, Grünert A.
    Clin Cardiol; 1993 Jul 05; 16(7):553-7. PubMed ID: 8348764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.